swelling at injection site tirzepatide Reaction : r/tirzepatidecompound The 3 Most Common GLP-1

Fatigue is a common and usually temporary adjustment effect, not a sign of treatment failure

The two drugs had been compared informally by reading SURMOUNT-1 against STEP 1, but methodological differences in those trials made the comparison imprecise

In the SURMOUNT-1 clinical trial, participants receiving 15 mg of tirzepatide weekly lost an average of 22.5% of their body weight over 72 weeks

Every pound of excess body weight increases the mechanical load on joints, the cardiovascular demand of movement, and the metabolic cost of daily activities

Michaowska J, Miller-Kasprzak E, Bogdaski P

You may have seen the news that Costco is now offering the name-brand medications Wegovy and Ozempic as part of the companys prescription program